The company has been honored as a big enterprise with profit and tax of over ten million yuan for many years, one of the top ten enterprises in the pharmaceutical industry of Hunan Province, and is a high-tech enterprise, a key listed enterprise, and an enterprise of Small Giant Program in Hunan Province. The company has a modernized pharmaceutical base of Chinese and western medicines, covering a total area of 273 acres; with tablets, capsules, granules, small-volume aqueous injections, lyophilized powder injection preparations, chemical synthesis, traditional Chinese medicine extraction and other production lines in line with the GMP standards, the implementation of the whole process of GMP quality management, to ensure product quality and safety of use, to provide consumers with reliable efficacy, safe use of the products and attentive service. The company has set up the first enterprise-run drug research institute in the province, and established long-term cooperative relationship with famous scientific research colleges and institutes at home and abroad, and there are national enterprise technology centers, postdoctoral workstations, pharmaceutical information and intellectual property centers and drug screening engineering technology research centers supported by the state, province and city, which have become the guarantee for the sustained development of the enterprise and one of the platforms for the industry's technological advancement, and have successfully applied for patents to the State Intellectual Property Office. It has successfully applied for 55 patents from the State Intellectual Property Office. Kangpu has more than 100 self-developed products, including two series of products: "Kangpu" brand chemical drugs and "Xilaile" brand proprietary Chinese medicines. The products are related to the treatment of digestive diseases, cardiovascular and cerebrovascular diseases, liver and kidney diseases, anti-microbial infections, nutritional supplements and auxiliary drugs, raw materials and other categories. The many carefully manufactured products provide reliable choices for the company to cooperate with customers and for consumers to cure diseases and save people's lives. Kang Pu brand Omeprazole enteric-coated capsule is the first choice for the treatment of peptic ulcer, and its "micro-pill technology" has been awarded the national invention patent; Xilailuo brand Kidney Supplement Tablet has been selected as a project of the National Torch Plan in 2010, and its preparation process has been awarded the protection of the national invention patent; Xilailuo brand Hepatoplex capsule has been included in the National Health Insurance Catalog, and has been supported by the project of modernization of Chinese medicine industry of the National Development and Reform Commission (NDRC). The modernization of traditional Chinese medicine industry is supported by the National Development and Reform Commission. The brands of "Kang Pu" and "Xilai Le" have been recognized as famous trademarks in Hunan Province, and the fist product Omeprazole, Kidney Supplement Tablets, Aqi Nourishing Blood Granules and many other products have been awarded the title of Hunan Famous Brand Products.